Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Other Operating Expenses (2019)

Neurogene (NGNE) has disclosed Other Operating Expenses for 4 consecutive years, with $4000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses fell 99.93% year-over-year to $4000.0, compared with a TTM value of $6.2 million through Sep 2025, up 4.65%, and an annual FY2024 reading of $22.6 million, changed N/A over the prior year.
  • Other Operating Expenses was $4000.0 for Q3 2025 at Neurogene, down from $6.2 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $6.2 million in Q4 2024 and bottomed at $4000.0 in Q3 2025.